INTEGRATED FILING — Other than Banks



General information about company

Scrip code 517562
NSE Symbol TRIGYN
MSEI Symbol NOTLISTED
ISIN INE948A01012
Name of Company Trigyn Technologies Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 30-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 23-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Software Services
Start date and time of board meeting 30-May-2025   17:00:00
End date and time of board meeting 30-May-2025   20:45:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
(III) Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2024-11-06
Indicate Company website link for updated RPT policy of the Company https://www.trigyn.com/investor-relations/codes-policies/related-party-transaction-policy
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NA


Financial Results — Other than Bank

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Revenue From Operations
Revenue from operations 470291000 1530791000
Other income 6761000 171233000
Total Income 477052000 1702024000
2 Expenses
(a) Cost of materials consumed 0 0
(b) Purchases of stock-in-trade 1559000 26638000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 2894000 -12724000
(d) Employee benefit expense 288866000 1106135000
(e) Finance costs 17255000 24738000
(f) Depreciation and amortisation expense
(g) Other Expenses
1 Other Expenses 123226000 441322000
Total other expenses 123226000 441322000
Total expenses 440993000 1620294000
3 Profit before exceptional and extraordinary items and tax
4 Exceptional items
5 Profit before extraordinary items and tax
6 Extraordinary items
7 Profit before tax 35863000 68809000
8 Tax Expense
Current tax 30504000 61983000
Deferred tax -1500000 -6860000
Total tax expenses 29004000 55123000
9 Net Profit Loss for the period from continuing operations
10 Profit (loss) from discontinuing operations before tax
11 Tax expense of discontinuing operations
12 Net profit (loss) from discontinuing operation after tax
13 Profit (loss) for period before minority interest
14 Share of profit (loss) of associates
15 Profit (loss) of minority interest
16 Net profit (Loss) for the period
17 Details of equity share capital
Paid-up equity share capital 30786000 30786000
Face value of equity share capital 10 10
18 Reserves excluding revaluation reserve 0
19 Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.22 0.44
Diluted earnings (loss) per share from continuing and discontinued operations 0.22 0.44
20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio
23 Disclosure of notes on financial results


Remarks

20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio


Cash flow statement — indirect

A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
1 Statement of cash flows
Cash flows from used in operating activities
Profit before extraordinary items and tax
2 Adjustments for reconcile profit (loss)
Adjustments to profit (loss)
Adjustments for finance costs 24738000
Adjustments for depreciation and amortisation expense 34185000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for unrealised foreign exchange losses gains 20361000
Adjustments for dividend income 148684000
Adjustments for share-based payments 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 109176000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments to profit (loss)
3 Adjustments for working capital
Adjustments for decrease (increase) in inventories -12939000
Adjustments for decrease (increase) in trade receivables
Adjustments for decrease (increase) in other current assets 0
Adjustments for increase (decrease) in trade payables
Adjustments for increase (decrease) in other current liabilities 0
Adjustments for provisions
Total adjustments for working capital
Total adjustments for reconcile profit (loss) -56886000
Net cash flows from (used in) operations 11923000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 83472000
Other inflows (outflows) of cash 11998000
Net cash flows from (used in) operating activities before extraordinary items
Proceeds from extraordinary items
Payment for extraordinary items
Net cash flows from (used in) operating activities -59551000
4 Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property plant and equipment 0
Purchase of property plant and equipment 982000
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 148684000
Interest received 22305000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Proceeds from government grants 0
Net cash flows from (used in) investing activities before extraordinary items
Proceeds from extraordinary items
Payment for extraordinary items
Net cash flows from (used in) investing activities 170007000
Cash flows from used in financing activities
Proceeds from issuing shares
Proceeds from issuing other equity instruments 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 0
Dividends paid 0
Interest paid 24738000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities before extraordinary items
Proceeds from extraordinary items
Payment for extraordinary items
Net cash flows from (used in) financing activities -29101000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 81355000
6 Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 81355000
Cash and cash equivalents cash flow statement at beginning of period 200899000
Cash and cash equivalents cash flow statement at end of period 282254000


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Equity and liabilities
1 Shareholders' funds
Share capital
Reserves and surplus
Money received against share warrants
Total shareholders' funds
2 Share application money pending allotment
3 Deferred government grants
4 Minority interest
5 Non-current liabilities
Long-term borrowings
Deferred tax liabilities (net) 0
Foreign currency monetary item translation difference liability account
Other long-term liabilities
Long-term provisions
Total non-current liabilities 99862000
6 Current liabilities
Short-term borrowings
Trade Payables
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other current liabilities 516382000
Short-term provisions
Total current liabilities 891408000
Total equity and liabilities 3024480000
Assets
1 Non-current assets
i Property, Plant and Equipment and Intangible assets
Property, Plant and Equipment 12053000
Producing properties
Intangible assets
Preproducing properties
Property, Plant and Equipment capital work-in-progress
Intangible assets under development or work-in-progress
Total Property, Plant and Equipment and Intangible assets
ii Non-current investments 1177371000
v Deferred tax assets (net) 20097000
vi Foreign currency monetary item translation difference asset account
vii Long-term loans and advances
viii Other non-current assets 136927000
Total non-current assets 1635698000
Current assets
Current investments 0
Inventories 88381000
Trade receivables
Cash and cash equivalents 282254000
Bank balance other than cash and cash equivalents 0
Short-term loans and advances
Other current assets 258900000
Total current assets 1388782000
Total assets 3024480000
Disclosure of notes on assets and liabilities


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets
Net Segment Asset
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities
Net Segment Liabilities
Disclosure of notes on segments




Signatory Details

Name of signatory
Designation of person
Place
Date


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Trigyn Technologies Limited Trigyn Technologies Inc. Subsidiary Company Any other transaction Expenses reimbursable/receivable by TTL 0 Not Applicable 0 2024-05-23 31223000 0 0
2 Trigyn Technologies Limited Trigyn Technologies Inc. Subsidiary Company Sale of goods or services 0 Not Applicable 0 2024-05-23 396871000 294000 0
3 Trigyn Technologies Limited Trigyn Technologies Inc. Subsidiary Company Advance 0 Not Applicable 0 2024-05-23 -179871000 -643718000 -478363000
4 Trigyn Technologies Limited Trigyn Technologies Inc. Subsidiary Company Dividend received 0 Not Applicable 0 2024-05-23 127166000 0 0
5 Trigyn Technologies Limited Leading Edge Infotech Limited Subsidiary Company Any other transaction Provisions / (written back) for doubtful Loan 0 Not Applicable 0 2024-05-23 -357000 -30640000 -30997000
6 Trigyn Technologies Limited Leading Edge Infotech Limited Subsidiary Company Loan 0 Not Applicable 0 2024-05-23 357000 30640000 30997000
7 Trigyn Technologies Limited Trigyn Technologies (India) Private Limited Subsidiary Company Any other transaction Provisions / (written back) for doubtful Loan 0 Not Applicable 0 2024-05-23 -46000 -192221000 -192267000
8 Trigyn Technologies Limited Trigyn Technologies (India) Private Limited Subsidiary Company Loan 0 Not Applicable 0 2024-05-23 46000 192221000 192267000
9 Trigyn Technologies Limited Trigyn Technologies Schweiz GMBH Subsidiary Company Any other transaction Expenses reimbursable/receivable by TTL 0 Not Applicable 0 2024-05-23 1200000 0 0
10 Trigyn Technologies Limited Trigyn Technologies Schweiz GMBH Subsidiary Company Sale of goods or services 0 Not Applicable 0 2024-05-23 15603000 2097000 18944000
11 Trigyn Technologies Limited Trigyn Eduexpert Private Limited Subsidiary Company Loan 2500000 Approved 2500000 2024-05-23 206000 228000 434000
12 Trigyn Technologies Limited Trigyn E-Governance Private Limited Subsidiary Company Loan 2500000 Approved 2500000 2024-05-23 264000 266000 530000
13 Trigyn Technologies Limited Trigyn FIN-TECH Private Limited Subsidiary Company Loan 2500000 Approved 2500000 2024-05-23 211000 2384000 2596000
14 Trigyn Technologies Limited Trigyn Healthcare Private Limited Subsidiary Company Loan 2500000 Approved 2500000 2024-05-23 208000 228000 435000
15 Trigyn Technologies Limited United Telecoms Limited Promoter Company Advance 0 Approved 0 2024-05-23 0 6821000 6821000
16 Trigyn Technologies Limited United Telecoms Limited Promoter Company Advance 50000000 Approved 50000000 2024-05-23 0 50000000 50000000
17 Trigyn Technologies Limited United Telecoms Limited Promoter Company Advance 0 Approved 0 2024-05-23 0 3455000 3455000
18 Trigyn Technologies Limited United Telecoms Limited Promoter Company Purchase of goods or services 50000000 Approved 50000000 2024-05-23 0 -116000 -116000
19 Trigyn Technologies Limited Aktivolt Celtek Private Limited Associates of Promoter Company Purchase of goods or services 3984000 Approved 3984000 2024-05-23 -2162000 2950000 2950000
20 Trigyn Technologies Limited Priyaraja Electronics Limited Associates of Promoter Company Advance 20000000 Approved 20000000 2024-05-23 0 20000000 20000000
21 Trigyn Technologies Limited Promuk Hoffmann International Limited Associates of Promoter Company Advance 0 Approved 0 2024-05-23 0 7000000 7000000
22 Trigyn Technologies Limited Dhira Software Labs Relatives of Key Management Personnel & Directors Purchase of goods or services 48000000 Approved 48000000 2024-05-23 -18382000 -1533000 -1630000
23 Trigyn Technologies Limited Amin Bhojani Chief Financial Officer Remuneration 0 Not Applicable 0 2024-05-23 2598000 0 0
24 Trigyn Technologies Limited Mukesh Tank Company Secretary, Vice President Legal Remuneration 0 Not Applicable 0 2024-05-23 2074000 0 0
25 Trigyn Technologies Limited R. Ganapathi Non-Executive Director Remuneration 4000000 Approved 4000000 2024-05-23 132000 0 0
26 Trigyn Technologies Limited Satyam Choudary Cherukuri Chairman & Non-Executive Director Remuneration 4000000 Approved 4000000 2024-05-23 2000000 0 0
Total value of transaction during the reporting period 379341000